208989-20-2Relevant academic research and scientific papers
Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
-
, (2008/06/13)
The invention relates to the use of tetrahydropyridine derivatives of the formula in which: R1is a halogen or a CF3, (C1-C4)alkyl or (C1-C4)alkoxy group; Y is a nitrogen atom or a CH group;
Use of 4-substituted tetrahydropyridines for making medicines acting on TGF-β1
-
Page column 15, (2010/02/04)
The invention relates to the use of a compound of formula (I): for the preparation of pharmaceutical compositions for increasing the circulating, cellular and extracellular levels of TGF-β1.
1-Phenylalkyl-1,2,3,6-tetrahydropyridines for treating Alzheimer's disease
-
, (2008/06/13)
PCT No. PCT/FR97/02286 Sec. 371 Date Jul. 27, 1999 Sec. 102(e) Date Jul. 27, 1999 PCT Filed Dec. 12, 1997 PCT Pub. No. WO98/25903 PCT Pub. Date Jun. 18, 1998The invention relates to compounds of the formula in which: Y is -CH- or -N-; R1 is hydrogen, a ha
